Who sells semaglutide legally in the UK — and what should you check?

What official guidance tells us about who can supply semaglutide

The starting point is the medicine's legal category. Wegovy (semaglutide) is a Prescription-Only Medicine under the Human Medicines Regulations 2012. That single fact settles a lot of questions: no seller, regardless of how it markets itself, can legally supply semaglutide to you without a valid prescription issued after a genuine clinical assessment.

The MHRA (the body that licences medicines in the UK) has published clear public guidance confirming that GLP-1 medicines are not assessed or intended for quick or cosmetic weight loss, and that access must follow proper clinical oversight. Their Yellow Card reporting scheme exists partly so patients can flag sellers who operate outside those boundaries.

Novo Nordisk, which manufactures Wegovy, supplies the medicine through the authorised UK wholesale supply chain. That chain ends at a GPhC-registered pharmacy, which is the only legal endpoint for a dispensed prescription. If a seller cannot be verified on the GPhC register, or does not require a prescription, it is not a legal route for a UK patient.

A question our prescribers hear most weeks is whether a private online pharmacy is really different from the NHS route, or whether it is somehow less legitimate. The answer is straightforward: a GPhC-registered online pharmacy operating under MHRA-regulated dispensing practices is every bit as lawful as a high-street pharmacy, it simply involves a private prescription rather than an NHS one. You can read more about the origins and development of semaglutide if that background helps you assess suppliers.

The two licensed forms of semaglutide for weight loss, and why the distinction matters for buyers

Not all semaglutide products on the market are licensed for weight loss, and this is a source of real confusion. Ozempic is also semaglutide, manufactured by Novo Nordisk, but its UK licence covers type 2 diabetes management, not weight management. The NHS medicines page for semaglutide distinguishes the two clearly. A seller offering Ozempic for weight loss is doing so outside its licensed indication, a significant regulatory issue that should give any buyer pause.

Wegovy injection (weekly, subcutaneous) has been licensed in the UK for weight management since 2023, with NICE subsequently recommending it under specific criteria. In June 2026, Wegovy tablets became the first oral GLP-1 medicine licensed in the UK for weight management, adding a needle-free option for eligible adults. Both remain prescription-only. The clinical trial evidence behind the injection (around 15% average weight reduction over 68 weeks in the STEP 1 study) is what NICE and the MHRA based their assessments on, and understanding the broader metabolic effects of Wegovy helps explain why that evidence matters.

If you are comparing sellers on price alone, it is worth looking at what the Wegovy price landscape across UK providers actually includes, consultation fees, prescription charges and aftercare costs vary considerably between suppliers.

Red flags that a semaglutide seller may not be operating lawfully

The MHRA has issued multiple warnings about counterfeit weight-loss injection pens circulating in the UK, including fake pens found to contain insulin rather than semaglutide. In 2025, enforcement teams seized roughly 20 million doses of illegally traded weight-loss medicines (approximately £45 million in street value), and the first illicit UK manufacturing site producing counterfeit tirzepatide pens was raided. Semaglutide has been a primary target for counterfeiters throughout this period.

Practical red flags include: a seller offering semaglutide without requiring a prescription or a clinical consultation; prices dramatically below the typical private market range; social media storefronts; sellers who cannot provide a GPhC registration number. Legitimate sellers will not offer discount codes or promotional pricing on prescription medicines, and if they do, that itself is a signal worth heeding. You can check whether a supplier is legally registered in seconds using the GPhC pharmacy register.

There is also a subtler issue: sellers who do require a prescription but conduct only a superficial, algorithm-driven clinical check. The legal framework around selling semaglutide requires genuine clinical assessment, not a box-ticking questionnaire. A prescriber (not software) should read your answers and make a clinical decision. It is also worth being aware of situations where semaglutide is not clinically appropriate, as a proper consultation will cover exactly this ground.

How to access semaglutide from a legitimate UK source

There are two main legitimate routes. The NHS route, for those who meet NICE criteria, runs through specialist weight management services, waiting times vary, and eligibility thresholds are strict. For adults who do not meet those criteria, or who do not want to wait, a regulated private online pharmacy is the legal alternative.

At nume, prescriptions are written by GPhC-registered Independent Prescribers who personally review every consultation the same day it arrives, not a bot, not an automated pass/fail system. Identity and weight are verified before treatment is approved. Once clinically cleared, orders placed before midday are dispatched the same working day by DPD and arrive the next working day in plain, unbranded packaging. There are no subscriptions; every repeat order receives a fresh clinical review.

You can explore all available weight-loss treatment options or read more about how medical weight management works before you decide. Our clinical team and prescriber profiles are published so you know exactly who is reviewing your case. If you have questions before starting, our support team is available seven days a week.

Speak to our prescribers through a free consultation, there is no obligation, and you will get a same-day clinical answer on whether semaglutide is appropriate for you.